Video Experimental Relacionado
Updated: May 5, 2026

09:58
A Method for Labeling Vasculature in Embryonic Mice
Published on: October 7, 2011
15.4K
Dismorfogénesis vascular causada por una mutación activadora en el receptor de la tirosina quinasa TIE2
M Vikkula1, L M Boon, K L Carraway
1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cell
|December 27, 1996
Resumen
Una mutación genética en TIE2 causa malformaciones venosas hereditarias (VMs). Este descubrimiento pone de relieve la vía de señalización TIE2.
Área de la Ciencia:
- Biología Vascular Biología Vascular
- Genética La genética.
- Biología del desarrollo Biología del desarrollo.
Sus antecedentes:
- Las malformaciones venosas (VM) son errores comunes de desarrollo vascular.
- Las VM presentan canales dilatados con músculo liso inconsistente.
- La base genética de las VM hereditarias no se entiende completamente.
Objetivo del estudio:
- Identificar la causa genética de las VM heredadas en dos familias.
- Para investigar el papel de la vía de señalización TIE2 en la morfogénesis venosa.
Principales métodos:
- Análisis de segregación de una mutación del gen TIE2 en familias afectadas.
- Expresión de proteínas en células de insectos para evaluar la actividad de la TIE2 quinasa.
- Análisis funcional de la mutación TIE2 identificada.
Principales resultados:
- Una mutación específica de error de sentido en el dominio de la TIE2 quinasa (R849W) segregado con VM heredadas.
- La mutación R849W condujo a un aumento de la actividad TIE2.
- Esta mutación activadora fue identificada en dos familias no relacionadas.
Conclusiones:
- Una mutación activadora en TIE2 causa malformaciones venosas hereditarias.
- La vía de señalización TIE2 es crucial para el desarrollo venoso normal.
- La comprensión de esta vía puede conducir a nuevas terapias de VM.
Videos de Conceptos Relacionados
Enzyme-linked Receptors
64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Notch Signaling Pathway
4.6K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Receptor Tyrosine Kinases
15.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K

